Zheng Chen

NPI: 1669878807
Total Payments
$3,199
2024 Payments
$1,705
Companies
21
Transactions
95
Medicare Patients
628
Medicare Billing
$48,453

Payment Breakdown by Category

Food & Beverage$2,999 (93.7%)
Gifts$200.00 (6.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,999 94 93.7%
Gift $200.00 1 6.3%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $811.33 22 $0 (2024)
Gilead Sciences, Inc. $353.02 10 $0 (2024)
Janssen Biotech, Inc. $300.64 11 $0 (2024)
PFIZER INC. $271.32 12 $0 (2024)
NESTLE HEALTHCARE NUTRITION INC. $220.00 2 $0 (2023)
INTRA-SANA LABORATORIES $200.00 1 $0 (2022)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $154.99 4 $0 (2024)
Ardelyx, Inc. $145.54 6 $0 (2024)
AIMMUNE THERAPEUTICS, INC. $125.21 2 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $113.35 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,705 60 ABBVIE INC. ($370.18)
2023 $805.09 22 ABBVIE INC. ($263.39)
2022 $212.53 2 INTRA-SANA LABORATORIES ($200.00)
2021 $476.51 11 AbbVie Inc. ($177.76)

All Payment Transactions

95 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/20/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $5.98 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/18/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $5.74 General
Category: Immunology
12/14/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $23.62 General
Category: LIVER DISEASE
12/13/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $13.36 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/13/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $7.07 General
Category: ENDOCRINOLOGY
12/13/2024 PFIZER INC. VELSIPITY (Drug) Food and Beverage In-kind items and services $1.40 General
Category: INFLAMMATION;PAIN
12/12/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $28.73 General
Category: Rare Disease
12/11/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $27.99 General
Category: ENDOCRINOLOGY
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $24.33 General
Category: INTERNAL MEDICINE
12/07/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $6.36 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/03/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $62.97 General
Category: GASTROENTEROLOGY
12/03/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $24.47 General
Category: Immunology
11/26/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $30.10 General
Category: Immunology
11/25/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $16.27 General
Category: GASTROENTEROLOGY
11/22/2024 Takeda Pharmaceuticals U.S.A., Inc. GATTEX (Drug) Food and Beverage In-kind items and services $17.31 General
Category: INTERNAL MEDICINE
11/19/2024 Celltrion USA Inc. VEGZELMA (Biological) Food and Beverage In-kind items and services $23.56 General
Category: ONCOLOGY
11/19/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $11.60 General
Category: GASTROENTEROLOGY
11/14/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $110.00 General
Category: GASTROENTEROLOGY
11/08/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $6.36 General
Category: ENDOCRINOLOGY
11/07/2024 Takeda Pharmaceuticals U.S.A., Inc. GATTEX (Drug) Food and Beverage In-kind items and services $30.36 General
Category: INTERNAL MEDICINE
11/05/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $26.32 General
Category: LIVER DISEASE
11/05/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $22.02 General
Category: IMMUNOLOGY
10/31/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $22.26 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/30/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $125.12 General
Category: Immunology
10/30/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $21.52 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 144 155 $38,755 $10,374
2022 4 251 291 $56,305 $20,622
2021 4 148 153 $40,105 $12,225
2020 4 85 89 $14,270 $5,232
Total Patients
628
Total Services
688
Medicare Billing
$48,453
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 59 68 $12,530 $3,744 29.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 29 31 $8,905 $2,670 30.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 41 41 $10,645 $2,627 24.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 15 15 $6,675 $1,333 20.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 121 153 $21,305 $9,174 43.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 40 48 $12,145 $4,492 37.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 65 65 $13,900 $4,408 31.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 25 25 $8,955 $2,547 28.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 56 58 $10,525 $3,847 36.6%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 49 49 $13,730 $3,516 25.6%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 23 23 $9,500 $2,698 28.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 20 23 $6,350 $2,165 34.1%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 27 27 $4,550 $1,658 36.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 28 28 $4,140 $1,453 35.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 17 21 $3,980 $1,405 35.3%
99202 New patient office or other outpatient visit, typically 20 minutes Office 2020 13 13 $1,600 $715.98 44.7%

About Zheng Chen

Zheng Chen is a Medical healthcare provider based in Lanham, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1669878807.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Zheng Chen has received a total of $3,199 in payments from pharmaceutical and medical device companies, with $1,705 received in 2024. These payments were reported across 95 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,999).

As a Medicare-enrolled provider, Chen has provided services to 628 Medicare beneficiaries, totaling 688 services with total Medicare billing of $48,453. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Medical
  • Location Lanham, MD
  • Active Since 11/17/2014
  • Last Updated 02/20/2017
  • Taxonomy Code 363AM0700X
  • Entity Type Individual
  • NPI Number 1669878807

Products in Payments

  • ZENPEP (Drug) $345.21
  • CREON (Drug) $341.48
  • TREMFYA (Drug) $211.18
  • RELTONE 200 MG (Drug) $200.00
  • ZEPOSIA (Drug) $187.69
  • XELJANZ (Drug) $158.47
  • XIFAXAN (Drug) $154.99
  • LINZESS (Drug) $151.79
  • IBSRELA (Drug) $145.54
  • STELARA (Biological) $132.95
  • VELSIPITY (Drug) $112.85
  • Vemlidy (Drug) $110.00
  • MAVYRET (Drug) $105.35
  • Biktarvy (Drug) $88.20
  • RESMETIROM (Drug) $79.28
  • UBRELVY (Drug) $67.88
  • GATTEX (Drug) $47.67
  • ENTYVIO (Biological) $43.48
  • DUPIXENT (Biological) $32.55
  • SUTAB (Drug) $29.22

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Doctors in Lanham